Literature DB >> 1940940

SEPIVAC: a community-based study of stroke incidence in Umbria, Italy.

S Ricci1, M G Celani, F La Rosa, R Vitali, E Duca, R Ferraguzzi, M Paolotti, D Seppoloni, N Caputo, C Chiurulla.   

Abstract

The SEPIVAC study is a community-based epidemiological survey of incidence and outcome of acute cerebrovascular disease in the Sixth Local Health Unit, Umbria, Italy (population 49,218). The study was carried out from 1 September 1986 to 31 August 1989. There were 375 patients who were registered with a first ever stroke, with a crude rate of 2.54 (95% confidence limits 2.29-2.81) per 1000 per year; the rate adjusted to the European population is 1.55 (CL 1.36-1.77). The age adjusted relative risk for males is 1.35 (CL 1.10-1.66). Up to 15% of the patients were not admitted to hospital during the acute phase of their disease. At least 286 (76.3%, CL 72-80.6) of the cases were due to cerebral ischaemia; in 56 of these (19.6%, CL 15-24.2) a clinical diagnosis of lacunar ischaemia was made. The 30 day case fatality rate was 20.3% (CL 16.2-24.3); between one and six months 7.5% (CL 5-10.6) of patients died.

Entities:  

Mesh:

Year:  1991        PMID: 1940940      PMCID: PMC1014472          DOI: 10.1136/jnnp.54.8.695

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Cerebral vascular accidents in patients over the age of 60. II. Prognosis.

Authors:  J RANKIN
Journal:  Scott Med J       Date:  1957-05       Impact factor: 0.729

2.  Rapid resolution of signs of primary intracerebral haemorrhage in computed tomograms of the brain.

Authors:  M S Dennis; J M Bamford; A J Molyneux; C P Warlow
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-08

3.  An evaluation of risk factors for stroke in a Dutch community.

Authors:  B Herman; A C Leyten; J H van Luijk; C W Frenken; A A Op de Coul; B P Schulte
Journal:  Stroke       Date:  1982 May-Jun       Impact factor: 7.914

4.  Epidemiologic features of cerebrovascular disease in Manitoba: incidence by age, sex and residence, with etiologic implications.

Authors:  H A Abu-Zeid; N W Choi; N A Nelson
Journal:  Can Med Assoc J       Date:  1975-09-06       Impact factor: 8.262

5.  A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke.

Authors:  J Bamford; P Sandercock; M Dennis; C Warlow; L Jones; K McPherson; M Vessey; G Fowler; A Molyneux; T Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

6.  Serological diagnosis of primary Sjögren's syndrome by means of human recombinant La (SS-B) as nuclear antigen.

Authors:  S Whittingham; G Naselli; L J McNeilage; R L Coppel; A D Sturgess
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

7.  Clinical diagnosis of the acute stroke syndrome.

Authors:  C M Allen
Journal:  Q J Med       Date:  1983

8.  First-year results of a community-based study of stroke incidence in Umbria, Italy.

Authors:  S Ricci; M G Celani; G Guercini; P Rucireta; R Vitali; F La Rosa; E Duca; R Ferraguzzi; M Paolotti; D Seppoloni
Journal:  Stroke       Date:  1989-07       Impact factor: 7.914

9.  Clinical distinction of cerebral haemorrhage and cerebral infarction.

Authors:  M J Harrison
Journal:  Postgrad Med J       Date:  1980-09       Impact factor: 2.401

10.  Value of computed tomography in patients with stroke: Oxfordshire Community Stroke Project.

Authors:  P Sandercock; A Molyneux; C Warlow
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19
View more
  13 in total

1.  Stroke incidence and survival in three Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group.

Authors:  W A Rocca; A Reggio; G Savettieri; G Salemi; F Patti; F Meneghini; F Grigoletto; L Morgante; R Di Perri
Journal:  Ital J Neurol Sci       Date:  1998-12

2.  Was it infarction or haemorrhage? A clinical diagnosis by means of the Allen score.

Authors:  M G Celani; M G Ceravolo; E Duca; P Minciotti; N Caputo; M Orlandini; S Ricci; L Provinciali
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

Review 3.  Services for people with stroke.

Authors:  D T Wade
Journal:  Qual Health Care       Date:  1993-12

Review 4.  Gender differences in neurological disease: role of estrogens and cytokines.

Authors:  Anna Członkowska; Agnieszka Ciesielska; Grazyna Gromadzka; Iwona Kurkowska-Jastrzebska
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

5.  Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study.

Authors:  A G Thrift; J J McNeil; A Forbes; G A Donnan
Journal:  BMJ       Date:  1999-03-20

6.  Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study.

Authors:  M Hollander; P J Koudstaal; M L Bots; D E Grobbee; A Hofman; M M B Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

7.  Incidence and prognosis of stroke in young adults: a population-based study in Ferrara, Italy.

Authors:  Elisabetta Groppo; Riccardo De Gennaro; Gino Granieri; Patrik Fazio; Edward Cesnik; Enrico Granieri; Ilaria Casetta
Journal:  Neurol Sci       Date:  2011-06-22       Impact factor: 3.307

8.  Does the incidence, severity, or case fatality of stroke vary in southern England?

Authors:  C D Wolfe; N A Taub; J Woodrow; E Richardson; F G Warburton; P G Burney
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

9.  Prognostic factors in patients with intracerebral haematoma.

Authors:  C L Franke; J C van Swieten; A Algra; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

Review 10.  Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack.

Authors:  Peter A G Sandercock; Lorna M Gibson; Ming Liu
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.